Arax Advisory Partners’s Conduent CNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.4K Buy
31,810
+31,019
+3,921% +$48.2K ﹤0.01% 3326
2026
Q1
$1.01K Buy
+791
New +$1.21K ﹤0.01% 3296
2025
Q4
Sell
-100,929
Closed -$283K 4164
2025
Q3
$283K Buy
+100,929
New +$273K ﹤0.01% 1114
2025
Q1
Sell
-532
Closed -$2.15K 2737
2024
Q4
$2.15K Sell
532
-150
-22% -$596 ﹤0.01% 1998
2024
Q3
$2.75K Hold
682
﹤0.01% 1939
2024
Q2
$2.22K Buy
682
+667
+4,447% +$2.27K ﹤0.01% 1927
2024
Q1
$51 Sell
15
-15
-50% -$52 ﹤0.01% 1299
2023
Q4
$110 Hold
30
﹤0.01% 1307
2023
Q3
$105 Hold
30
﹤0.01% 1297
2023
Q2
$102 Hold
30
﹤0.01% 1248
2023
Q1
$103 Hold
30
﹤0.01% 1251
2022
Q4
$122 Buy
+30
New +$115 ﹤0.01% 1247
2021
Q4
Sell
-30
Closed 1144
2021
Q3
$0 Hold
30
﹤0.01% 1005
2021
Q2
$0 Buy
+30
New +$219 ﹤0.01% 918
2018
Q4
Sell
-62
Closed -$1K 561
2018
Q3
$1K Buy
+62
New +$1.27K ﹤0.01% 596

Other funds holding CNDT

Arax Advisory Partners's CNDT Position: Q2 2026 in Review

Arax Advisory Partners increased its Conduent (CNDT) stake by 3,921% in Q2 2026, buying an estimated $48.2K and bringing the position to 31,810 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

Arax Advisory Partners first reported a position in CNDT in Q3 2018 and has held it in 15 quarters since. The position peaked at $283K in Q3 2025. 190 funds tracked by Wall St. Rank hold CNDT as of Q2 2026.

  • Arax Advisory Partners held 31,810 shares of Conduent worth $46.4K as of Q2 2026.
  • Arax Advisory Partners bought 31,019 Conduent shares in Q2 2026, an estimated $48.2K.
  • Conduent made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3326 holding.
  • Arax Advisory Partners first reported a position in Conduent in Q3 2018 and has held it in 15 quarters since.
  • Arax Advisory Partners's Conduent position peaked at $283K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Conduent as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.